CN104491716A - Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule - Google Patents
Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule Download PDFInfo
- Publication number
- CN104491716A CN104491716A CN201410764228.8A CN201410764228A CN104491716A CN 104491716 A CN104491716 A CN 104491716A CN 201410764228 A CN201410764228 A CN 201410764228A CN 104491716 A CN104491716 A CN 104491716A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- traditional chinese
- capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 35
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 206010025323 Lymphomas Diseases 0.000 title abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 11
- 238000011049 filling Methods 0.000 claims description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000195474 Sargassum Species 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 108010052008 colla corii asini Proteins 0.000 claims description 8
- 239000009286 sanguis draxonis Substances 0.000 claims description 8
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 24
- 230000001737 promoting effect Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 235000007519 Chimonanthus praecox Nutrition 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 241000283074 Equus asinus Species 0.000 abstract 1
- 241001189830 Fissistigma Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 240000001359 Origanum dictamnus Species 0.000 abstract 1
- 235000015987 Origanum dictamnus Nutrition 0.000 abstract 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000010674 Prunella vulgaris Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 20
- 210000004185 liver Anatomy 0.000 description 17
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 201000000736 Amenorrhea Diseases 0.000 description 8
- 206010001928 Amenorrhoea Diseases 0.000 description 8
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 231100000540 amenorrhea Toxicity 0.000 description 8
- 208000017604 Hodgkin disease Diseases 0.000 description 7
- 208000021519 Hodgkin lymphoma Diseases 0.000 description 7
- 208000010747 Hodgkins lymphoma Diseases 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000036737 immune function Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 241000219095 Vitis Species 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000000527 lymphocytic effect Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010041660 Splenomegaly Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 206010019847 hepatosplenomegaly Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000321096 Adenoides Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019754 Hepatitis cholestatic Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000017605 Hodgkin disease nodular sclerosis Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 206010027295 Menometrorrhagia Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 206010028570 Myelopathy Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000007123 Pulmonary Atelectasis Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- -1 antibacterial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000010322 bone marrow transplantation Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 231100000838 cholestatic hepatitis Toxicity 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 208000018555 lymphatic system disease Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the field of traditional Chinese medicines and in particular relates to a traditional Chinese medicine capsule for treating lymphoma and a preparation method of the traditional Chinese medicine capsule. The traditional Chinese medicine capsule is prepared from the following medicinal raw materials in parts by weight: 15-20 parts of prunella vulgaris, 10-15 parts of algae, 10-15 parts of airpotato yam rhizome, 20-25 parts of salvia miltiorrhiza, 8-10 parts of sangusis draconis flower, 8-10 parts of ligusticum wallichii, 15-20 parts of rhizoma zedoariae, 8-10 parts of ground beetle, 8-10 parts of centipede, 10-15 parts of red peony root, 15-20 parts of turtle shell, 25-30 parts of oldenlandia diffusa, 35-40 parts of glaucescent fissistigma root, 35-40 parts of root of wintersweet, 8-10 parts of astragaloside, 10-15 parts of radix pseudostellariae, 10-15 parts of bighead atractylodes rhizome, 6-8 parts of jujube, 8-10 parts of angelica sinensis, 8-10 parts of radix rehmanniae, 8-10 parts of radix ophiopogonis, 8-10 parts of Chinese wolfberry and 15-20 parts of donkey hide gelatin. The traditional Chinese medicine capsule has the efficacies of clearing away heat and toxic materials, promoting blood circulation and removing blood stasis, has remarkable curative effect of treating the lymphoma and is worthy of being clinically and widely popularized and applied.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to one and treat lymphadenomatous Chinese medicinal capsule and preparation method thereof.
Background technology
Lymphoma is the malignant tumor originating from lymphohematological, and main manifestations is Silent Neuritis lymphadenectasis, hepatosplenomegaly, and each histoorgan of whole body all can be got involved, the heat that occurs together, night sweat, become thin, the General Symptoms such as pruritus.
Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) two class is divided into according to oncocyte.Pathological characteristics Hodgkin lymphoma be in tumor tissue containing lymphocyte, eosinophilic granulocyte, plasma cell and specific in-Si cell, HL is divided into nodositas to be rich in lymphocytic type and classic according to histological type, and the latter comprises lymphocytic predominance, nodular sclerosis, mixed cell type and lymphocytic depletion.NHL sickness rate is far above HL, it is the summation with very strong one group of heterogeneous independent disease, lymphocyte, histiocyte or skein cell that on pathology, mainly differentiation degree is different, according to the natural history of NHL, three large Clinical types can be classified as, i.e. Highly invasive, aggressive and indolent lymphoma.According to different lymphocytes originate, B cell, T cell and NK cell lymphoma can be divided into.
Malignant lymphoma has a quite heterogeneous large class tumor, although be apt to occur in lymph node, due to lymphoid characteristic distributions, makes lymphoma belong to systemic disease, almost can invade any tissue of whole body and organ.Therefore, the clinical manifestation of malignant lymphoma had both had certain common feature, simultaneously according to different histological type, by invading position and scope also exists again very large difference.C-XF has circle or similar round or lobulated shade, lesion growth can be oppressed bronchus and be caused pulmonary atelectasis, and center of tumor necrosis sometimes forms cavity.Some pulmonary lesions show as diffuse interstitial and sexually revise, and now clinical symptoms is obvious, often have cough, expectoration, breathe hard, dyspnea, and secondary infection can have heating; Malignant lymphoma can invade cardiac muscle and pericardium, shows as pericardial effusion, and lymphoma is invaded cardiac muscle and shown as cardiomyopathy, can have arrhythmia, the performances such as electrocardiographic abnormality; Abdominal part performance spleen is invaded position under the modal diaphragm of HL.Gastrointestinal tract is then the outer diseased region of the modal knot of NHL.After mesentery, peritoneum and iliac fossa lymph node etc. be also the common infringement position of lymphoma; Cutaneous manifestations malignant lymphoma can former or secondary skin be invaded, and is more common in NHL; The bone marrow involvement of bone marrow malignant lymphoma shows as bone marrow and is invaded or merge leukemia, one of many genus terminal stage of a disease performances, and the overwhelming majority is NHL; Manifestations of nervous system, as other performances such as progressive multifocal leukoencephalopathy, subacute necrotic myelopathy, sensation or mobility's peripheral neuropathy and multiple myopathy etc.Malignant lymphoma can also former or tissue, larynx, skeleton and muscular soft tissues etc. after being secondary to brain, epidural, testis, ovary, vagina, cervix uteri, mammary gland, thyroid, adrenal gland, eye socket ball, and complicated clinical manifestation is various.
Lymphoma has height heterogeneity, therefore in treatment, also difference is very large, and different pathological types and lymphoma by stages all exist very big difference from treatment intensity and prognosis.Lymphadenomatous Therapeutic Method mainly contains radiotherapy, chemotherapy, bone marrow transplantation, operative treatment are several, but concrete patient also should make a concrete analysis of according to patient's practical situation.Primary disease Chinese and western medicine there is no specific short and medicine can cure this disease, and dialectical the treating of the traditional Chinese medical science still has some superiority with symptomatic treatment, but curative effect of medication is poor mostly at present, side effect is large, institute thinks a kind of instant effect of research, the medicine had no side effect, and has become one of important topic of various big hospital research.
Summary of the invention
According to above the deficiencies in the prior art, the invention discloses a kind of can heat-clearing and toxic substances removing, eliminating stagnation of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling the lymphadenomatous Chinese medicinal capsule for the treatment of and preparation method thereof.
One of the present invention treats lymphadenomatous Chinese medicinal capsule, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 15-20 part, Sargassum 10-15 part, Rhizoma Dioscoreae Bulbiferae 10-15 part, Radix Salviae Miltiorrhizae 20-25 part, Sanguis Draxonis 8-10 part, Rhizoma Chuanxiong 8-10 part, Rhizoma Curcumae 15-20 part, Eupolyphaga Seu Steleophaga 8-10 part, Scolopendra 8-10 part, Radix Paeoniae Rubra 10-15 part, Carapax Trionycis 15-20 part, Herba Hedyotidis Diffusae 25-30 part, Radix Fissistigmatis Glaucescentis 35-40 part, Radix Chimonanthi praecocis 35-40 part, Radix Astragali 8-10 part, Radix Pseudostellariae 10-15 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Fructus Jujubae 6-8 part, Radix Angelicae Sinensis 8-10 part, Radix Rehmanniae 8-10 part, Radix Ophiopogonis 8-10 part, Fructus Lycii 8-10 part, Colla Corii Asini 15-20 part.
One treats lymphadenomatous Chinese medicinal capsule, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 18 parts, Sargassum 12 parts, Rhizoma Dioscoreae Bulbiferae 13 parts, Radix Salviae Miltiorrhizae 22 parts, Sanguis Draxonis 9 parts, Rhizoma Chuanxiong 9 parts, Rhizoma Curcumae 13 parts, Eupolyphaga Seu Steleophaga 9 parts, Scolopendra 9 parts, Radix Paeoniae Rubra 12 parts, Carapax Trionycis 18 parts, Herba Hedyotidis Diffusae 28 parts, Radix Fissistigmatis Glaucescentis 36 parts, Radix Chimonanthi praecocis 36 parts, the Radix Astragali 9 parts, Radix Pseudostellariae 12 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, 7 parts, Fructus Jujubae, Radix Angelicae Sinensis 9 parts, 9 parts, the Radix Rehmanniae, Radix Ophiopogonis 9 parts, Fructus Lycii 9 parts, 18 parts, Colla Corii Asini.
Treat a preparation method for lymphadenomatous Chinese medicinal capsule, comprise the following steps:
1) decoct with water twice by above-mentioned weight ratio weighting raw materials, add 8 times of water gagings at every turn, first time decocts 2 hours, and second time decocts 1 hour, and merging filtrate, after filtration, is dried to fine powder;
2) by step 1) in fine powder add anhydrous grape Icing Sugar mix homogeneously;
3) above-mentioned mixed-powder is put into capsule filling machine and carry out filling, namely obtain the capsule of every 0.5-0.6 gram.
Instructions of taking, every day 3 times, each 2, one after each meal, warm water takes, and within 14 days, is a course for the treatment of.
Pharmacology analysis:
Spica Prunellae: acrid in the mouth, hardship, cold in nature.Return liver, gallbladder meridian.Can relieve inflammation or internal heat, improving eyesight, eliminating stagnation, detumescence.For conjunctival congestion and swelling pain, order pearl nyctalgia, has a headache dizzy, scrofula, goiter, and acute mastitis swells and ache; Thyromegaly, tuberculous lymphadenitis, cyclomastopathy, hypertension.
Sargassum: bitter in the mouth, salty, cold in nature.Return liver, stomach, kidney channel.Softening the hard mass; Expectorant; Diuretic; Detumescent.Can eliminating stagnation gas carbuncle, abdomen inner product block, distending pain, abdomen hollow are rung.Also can descend 12 kinds of edema, treat between skin and gather sudden and violent bursting, stay depressed heat, diuresis.
Rhizoma Dioscoreae Bulbiferae: bitter in the mouth, pungent, cool in nature.Can removing toxic substances and promoting subsidence of swelling, dissipating phlegm and resolving masses, cooling blood for hemostasis.For thyromegaly, tuberculous lymphadenitis, laryngopharynx swelling and pain, spits blood, spitting of blood, pertussis, cancerous protuberance.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature.Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness.For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia; Hepatosplenomegaly, angina pectoris.
Sanguis Draxonis: sweet-salty, property put down, GUIXIN, Liver Channel, can dissipating blood stasis analgesic therapy, hemostasis, promoting tissue regeneration and ulcer healing.Main traumatic injury, ecchymoma due to internal injury, dysmenorrhea, postpartum stagnation is suffered from abdominal pain, continuous bleeding due to traumatic injury, scrofula, ecthyma unhealed for long time and hemorrhoid.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature.Return liver, gallbladder, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.For pacifying nerve, positive wind syndrome of head headache, lump in the abdomen is suffered from abdominal pain, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
Rhizoma Curcumae: acrid in the mouth, hardship, warm in nature.Return liver, spleen channel.Can circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving.For Dan abdominal mass mass in the abdomen, blood stasis amenorrhea, food stagnation distending pain; Early cervical carcinoma.
Eupolyphaga Seu Steleophaga: cold in nature, returns Liver Channel.Function: lower blood stasis, eliminating mass abdominal mass, treats injured: for blood stasis amenorrhea, traumatic injury and lump in the abdomen lump; Eliminating stasis to stop pain: the liver splenomegaly pain caused for blood stasis and lumbar muscle strain, to sprain.
Scolopendra: acrid in the mouth, warm in nature; Poisonous, return Liver Channel.Endogenous wind stopping spasmolytic, merit poison eliminating stagnation, removing obstruction in the collateral to relieve pain.For infantile convulsion, tic spasm, middle air port is askew, hemiplegia, tetanus, rheumatoid arthritis stubborn, skin infection, scrofula, venom.
Radix Paeoniae Rubra: bitter in the mouth, cold nature; Return Liver Channel; Function clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.Cure mainly maculae caused by violent heat pathogen, hematemesis and epistaxis, discharging fresh blood stool, conjunctival congestion and swelling pain, carbuncle skin infection, amenorrhea, dysmenorrhea, metrorrhagia and leukorrhagia stranguria with turbid discharge, the stagnant hypochondriac pain of the stasis of blood, hernia abdominal mass is gathered, injury from falling down.For maculae caused by violent heat pathogen, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen is suffered from abdominal pain, injury from falling down, carbuncle skin infection.Modern pharmacology research proves, Radix Paeoniae Rubra has antipyretic, antibacterial, spasmolytic, analgesic activity, and humoral and cellular immune response can be suppressed to react, clinical verification shows, radix paeoniae rubrathe for treating acute cholestasis type hepatitis, slow type Serious cholestatic hepatitis of living have obvious pause and transition in rhythm or melody jaundice and choleretic effect.
Carapax Trionycis: salty in the mouth, cold nature.Return liver, kidney channel.Replenishing YIN and removing heat, suppressing the hyperactive liver to relieve the wind syndrome, hard masses softening and resolving.Control consumptive fever hectic fever due to YIN-deficiency, stirring of wind due to deficiency of YIN, malaria with general debility malaria with splenomegaly, lump in the abdomen mass beside the umbilicus, amenorrhea menometrorrhagia, pediatric epilepsy scared.
Herba Hedyotidis Diffusae: bitter in the mouth, light, cold in nature; Primary efficacy is heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness; Cure mainly dyspnea and cough due to lung-heat, laryngopharynx swelling and pain, acute appendicitis, furuncle and phyma skin infection, venom, the puckery pain of pyretic stranguria, edema, dysentery, enteritis, jaundice due to damp-heat, be good at the multiple cancerous protuberance for the treatment of.Modern pharmacology proves, Herba Hedyotidis Diffusae treatment acute icterohepatitis is evident in efficacy.
Radix Fissistigmatis Glaucescentis: warm in nature, acrid in the mouth is puckery, returns Liver Channel, can wind-damp dispelling, restores menstrual flow and invigorates blood circulation, and can stop blooding.The diseases such as main air pain of dampness syndrome, menoxenia, traumatic injury, fracture and traumatic hemorrhage.
Radix Chimonanthi praecocis: bitter in the mouth, cool in nature.Can wind-expelling pain-stopping, vital energy regualting and blood circulation-promoting and relieving cough and asthma.The disease such as main air pain of dampness syndrome, anemofrigid cold, traumatic injury, epigastric pain, asthma, epersalgia cough, furuncle swelling toxin.
The Radix Astragali: sweet in the mouth, warm in nature.Return lung, spleen channel.Can invigorating QI to consolidate the body surface resistance, diuresis poison holding, evacuation of pus, expelling pus and promoting granulation.Weak for the deficiency of vital energy, anorexia and loose stool, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, deficiency of vital energy edema, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency dull yellowish colored skin, interior-heat is quenched one's thirst; Chronic nephritis proteinuria, diabetes.
Radix Pseudostellariae: sweet in the mouth, micro-hardship, property is put down.Return spleen, lung meridian.Can replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung.Tired for insufficiency of the spleen body, inappetence, weak after being ill, deficiency of both vital energy and Yin, spontaneous perspiration is thirsty, dryness of the lung dry cough.
The Rhizoma Atractylodis Macrocephalae: this product sweetness and bitterness is warm in nature, main returns taste warp, and with spleen invigorating, dampness for Main Function, what praised by forefathers is " spleen air making-up and spleen enlivening first key medicine ".The spleen has the function to transport and transform nutrients because of deficiency of spleen-QI, and transporting is lost strong, often water wet in raw, cause lack of appetite, loose stool or have loose bowels, all cards of phlegm retention, edema, leukorrhagia.
Fructus Jujubae: sweet in the mouth, pungent, warm in nature; Return spleen, stomach warp; Cure mainly trusted subordinate's pathogen, few body fluid, physical weakness, frightened, heaviness of limbs; Function regulating the spleen and stomach, supports the flat gastric qi of temper, invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind; Logical nine orifices, helps Bu Erjing, mends weak breath, and hundred medicines.Taking for a long time to make light of one's life by commiting suicide prolongs life.
Radix Angelicae Sinensis: sweet in the mouth, pungent, warm in nature.Return liver, the heart, spleen channel.Enrich blood and invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.For blood deficiency and yellow complexion, dizzy cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down, ulcer sores.Radix Angelicae Sinensis (processed with wine) promoting blood circulation to restore menstrual flow.For amenorrhea dysmenorrhea, rheumatic arthralgia, injury from falling down.
The Radix Rehmanniae: clearing away heat and promoting production of body fluid, after cool, hemostasis, yin nourishing, promotes the production of body fluid; For calentura excessive thirst, send out speckle dermexanthesis, yin asthenia generating intrinsic heat, haematemesis, epistaxis, diabetes, infectious hepatitis.
Radix Ophiopogonis: micro-sugariness is bitter, cold in nature; Enter lung stomach heart channel; YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire; For dryness of the lung dry cough, vexed insomnia, interior-heat is quenched one's thirst.
Fructus Lycii: sweet in the mouth, property is put down, and returns liver, kidney, lung meridian.Function the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, the lung moistening and production of body fluid promoting.The treatment hepatic and renal YIN deficiency, essence and blood loses few, and weak idle dynamic, forgetful insomnia, soreness of waist and knee joint, impotence and seminal emission, vertigo and tinnitus, blurring of vision, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, cough due to consumptive disease etc.Modern pharmacological research is reported, Fructus Lycii have improve and immunity moderation function, antioxidation, defying age, protect the liver, promote body injury reparation, promote hemopoietic function, protection endocrinal glands, protection retina, enhancing resisting fatigue and the effect of hypoxia-bearing capability.Be usually used in treatment senile dementia caused by liver and kidney deficiency disease, doublely control cough due to consumptive disease, the vexed disease such as to quench one's thirst.
Colla Corii Asini: feeble QI, taste is micro-sweet; To enrich blood YIN nourishing, moisturize, hemostasis.For blood deficiency and yellow complexion, dizzy cardiopalmus, dysphoria and insomnia, xeropulmonary cough.
Chinese medicine disclosed by the invention has heat-clearing and toxic substances removing, effect of eliminating stagnation of regulating the flow of vital energy, blood circulation promoting and blood stasis dispelling, evident in efficacy to lymphadenomatous treatment, instant effect, can improve immune function of human body, anticancer generates and diffusion, and playing the effect of anti-inflammation, expelling pus and toxin by strengthening QI, mass dissipating and swelling eliminating, medicinal raw material is easy to get, with low cost, cure rate is high, non-relapse after healing, safe and reliable, clinic wide popularization and application.
Efficacy evaluation:
Cure: lump disappears, symptom and sign disappears, and does not recur after drug withdrawal;
Effective: lump obviously reduces, symptom and sign is obviously alleviated, and recurs lighter after drug withdrawal;
Effective: lump reduces to some extent, symptom and sign partial rcsponse, recurs after drug withdrawal to some extent;
Invalid: symptom and sign is not improved or increases the weight of.
Select the routine clinical observation of Lymphoma 120 of making a definite diagnosis, patient is divided into treatment group (taking Chinese medicinal capsule of the present invention) and each 60 examples of matched group (injection injection RhIL-2 125Ala) two groups at random, wherein all male 60 examples, women 60 example, 25 ~ 75 years old age, 43 years old mean age, the course of disease 1 ~ 20 year.The course of disease, the degrees of symptoms for the treatment of group and matched group two groups of cases are basically identical, without significant difference, have comparability.
Statistical result is as follows:
| Number of cases | Cure | Effective | Take a turn for the better | Invalid | Inefficiency | |
| Matched group | 60 | 2 | 4 | 5 | 49 | 81.67％ |
| Treatment group | 60 | 41 | 16 | 2 | 1 | 1.67％ |
Result: cure in 60 routine patients in treatment group and effectively account for 57 routine, accounting for 95%; Cure+manifest+take a turn for the better 59 examples, accounts for 98.33%.Far above the effective percentage of 18.33% of matched group, so in sum, Chinese medicinal capsule of the present invention has good curative effect to lymphadenomatous treatment.
Below enumerate several model case:
Case 1: grandson, female, 30 years old, have lump under patient's axillary fossa, low grade fever, health is weak, with slight pruritus, hospital diagnosis was early stage lymphoma afterwards, after take capsule of the present invention, after the course for the treatment of, lump reduces, after continuing to take 3 courses for the treatment of, symptom is obviously improved, then after taking 2 courses for the treatment of, patients ' recovery is left hospital, and follows up a case by regular visits to 4 months without recurrence.
Case 2: Lee, man, 28 years old, patient's inguinal lymphadenopathy, health is weak, night sweat, uncomfortable in chest, hospital diagnosis was lymphoma afterwards, after take capsule of the present invention, after the course for the treatment of, lump reduces, after continuing to take 3 courses for the treatment of, symptom is obviously improved, then after taking 2 courses for the treatment of, patients ' recovery is left hospital, and follows up a case by regular visits to 4 months without recurrence.
Summarized the experience by clinical case, lymphoma is primary in lymph node or adenoid malignant tumor.Long-term dietary structure, the factors such as living habit cause the excessive acidify of body constitution, and the function of human body integral declines rapidly, and lymphadenomatous pathogenic factor is also indefinite, and viral infection, immunosuppressant, bacteriological infection, environmental factors are all cause its pathogenic factor.Immunologic function does not have important immunosurveillance, the cell of sudden change can not be eliminated, and lymphoma just occurs than being easier to.
Immune system can naturally resist some pathogen invasion and attack but when ill, as heavy cold, fever time immunologic function obviously decline.
Contact some chemical factors or overtired also can break immune balance, become the main inducing that Partial tumors patient falls ill.No matter so patient that what obtained was sick, all should take a good rest in order to disease recovery, if there is immunodeficiency can not self-healing time, in requisition for some medical intervention, can help to a certain extent to improve immunologic function.
And when the nervous pressure of people is large time, immunologic function can be suppressed, can not " tumor like cell " in time in purged body, finally may lead oncogenic generation.So note in life keeping the leisure of appropriateness, good phychology, be helpful to health.
Improve immunity and can effectively prevent lymphadenomatous generation, once be diagnosed as lymphoma, patient does not have heavy psychological burden yet, because early stage Hodgkin lymphoma more than 80% can be cured, the long-term survival rate of patients with non Hodgkin lymphoma also can reach more than 50%, and the indolent lymphoma survival of patients time can reach 8 to 10 years.
Daily life should be careful in one's diet life more, thus prevention lymphoma, comprise following 4 points:
1, do not eat salty and peppery food too much, do not eat overheated, supercool, expired and rotten food
2, there is good phychology answering pressure, strike a proper balance between work and rest, not overtired.Visible pressure is important cancer inducement
3, strengthen physical training, how health invigorating, move in the sun, and having more antiperspirant can excrete body inner acidic material with perspiration, avoids the formation of acidic physique.
4, life wants rule, the erratic people of living habit, as sing karaoke all night, play Mah-Jong, the life such as not go home all night is irregular, all can increase the weight of body constitution acidify, easy cancer stricken.Good living habit should be formed, thus keep alkalescence body constitution, make various Cancerous disease away from oneself.
In clinical case, hypoimmunity is a more extensive feature of tumor group of people at high risk.The children of addiction online, the working clan that operating pressure is excessive, is in fatigue, biotonus for a long time, stays up late for a long time, cause hypoimmunity, so patient must note regularity in one's life, rational diet, could effectively prevent disease.
For suffering from lymphadenomatous patient, diet nursing notes following 4 main points:
1, have more meals a day but less food at each, the high nutritious food of the little heat of some volumes can be increased outside breakfast, lunch and dinner, as chocolate, rusk, egg products.
2, food is fewer but better: there will be the symptoms such as nausea and vomiting diarrhoea, inappetence during one's sickness, majority's appetite is less.Therefore food selection should be high quality protein matter, and phitosite is various alternately, adheres to feed, patient because of vomiting food intake dose inadequate time, glucose, aminoacid, albumen etc. can be assisted from vein.
3, eat more and be rich in the abundant food of vitamin C and vitamin A.Medical research proves, vitamin C can strengthen interstitial function in cell, is the first barrier stoping cancerous cell to generate diffusion.Strengthen systemic resistance power, the hypertrophy of anticancer.Many vegetable and fruits, as Fructus Lycopersici esculenti, Fructus Crataegi, Fructus Citri junoris, Fructus Citri Limoniae, Fructus Jujubae etc., abundanter containing vitamin C, answer polyphagia to use.
4, nurse one's health diet to the ill: in diet, increase some flavoring agent, make taste of food delicious, appetite stimulator.Easily to choke after feed food, can lack of appetite slag liquid food.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described, but the present invention is not limited to specific embodiment.
Embodiment 1:
One treats lymphadenomatous Chinese medicinal capsule, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 15 parts, Sargassum 15 parts, Rhizoma Dioscoreae Bulbiferae 10 parts, Radix Salviae Miltiorrhizae 25 parts, Sanguis Draxonis 8 parts, Rhizoma Chuanxiong 10 parts, Rhizoma Curcumae 15 parts, Eupolyphaga Seu Steleophaga 10 parts, Scolopendra 8 parts, Radix Paeoniae Rubra 15 parts, Carapax Trionycis 15 parts, Herba Hedyotidis Diffusae 30 parts, Radix Fissistigmatis Glaucescentis 35 parts, Radix Chimonanthi praecocis 40 parts, the Radix Astragali 8 parts, Radix Pseudostellariae 15 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, 8 parts, Fructus Jujubae, Radix Angelicae Sinensis 8 parts, 10 parts, the Radix Rehmanniae, Radix Ophiopogonis 8 parts, Fructus Lycii 10 parts, 15 parts, Colla Corii Asini.
Embodiment 2:
One treats lymphadenomatous Chinese medicinal capsule, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 20 parts, Sargassum 10 parts, Rhizoma Dioscoreae Bulbiferae 15 parts, Radix Salviae Miltiorrhizae 20 parts, Sanguis Draxonis 10 parts, Rhizoma Chuanxiong 8 parts, Rhizoma Curcumae 20 parts, Eupolyphaga Seu Steleophaga 8 parts, Scolopendra 10 parts, Radix Paeoniae Rubra 10 parts, Carapax Trionycis 20 parts, Herba Hedyotidis Diffusae 25 parts, Radix Fissistigmatis Glaucescentis 40 parts, Radix Chimonanthi praecocis 35 parts, the Radix Astragali 10 parts, Radix Pseudostellariae 10 parts, the Rhizoma Atractylodis Macrocephalae 15 parts, 6 parts, Fructus Jujubae, Radix Angelicae Sinensis 10 parts, 8 parts, the Radix Rehmanniae, Radix Ophiopogonis 10 parts, Fructus Lycii 8 parts, 20 parts, Colla Corii Asini.
Embodiment 3:
One treats lymphadenomatous Chinese medicinal capsule, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 18 parts, Sargassum 12 parts, Rhizoma Dioscoreae Bulbiferae 13 parts, Radix Salviae Miltiorrhizae 22 parts, Sanguis Draxonis 9 parts, Rhizoma Chuanxiong 9 parts, Rhizoma Curcumae 13 parts, Eupolyphaga Seu Steleophaga 9 parts, Scolopendra 9 parts, Radix Paeoniae Rubra 12 parts, Carapax Trionycis 18 parts, Herba Hedyotidis Diffusae 28 parts, Radix Fissistigmatis Glaucescentis 36 parts, Radix Chimonanthi praecocis 36 parts, the Radix Astragali 9 parts, Radix Pseudostellariae 12 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, 7 parts, Fructus Jujubae, Radix Angelicae Sinensis 9 parts, 9 parts, the Radix Rehmanniae, Radix Ophiopogonis 9 parts, Fructus Lycii 9 parts, 18 parts, Colla Corii Asini.
Embodiment 4:
Treat a preparation method for lymphadenomatous Chinese medicinal capsule, comprise the following steps:
1) decoct with water twice by the weight ratio weighting raw materials in embodiment 1, add 8 times of water gagings at every turn, first time decocts 2 hours, and second time decocts 1 hour, and merging filtrate, after filtration, is dried to fine powder;
2) by step 1) in fine powder add anhydrous grape Icing Sugar mix homogeneously;
3) above-mentioned mixed-powder is put into capsule filling machine and carry out filling, namely obtain the capsule of 0.5 gram every.
Instructions of taking, every day 3 times, each 2, one after each meal, warm water takes, and within 14 days, is a course for the treatment of.
Embodiment 5:
Treat a preparation method for lymphadenomatous Chinese medicinal capsule, comprise the following steps:
1) decoct with water twice by the weight ratio weighting raw materials in embodiment 2, add 8 times of water gagings at every turn, first time decocts 2 hours, and second time decocts 1 hour, and merging filtrate, after filtration, is dried to fine powder;
2) by step 1) in fine powder add anhydrous grape Icing Sugar mix homogeneously;
3) above-mentioned mixed-powder is put into capsule filling machine and carry out filling, namely obtain the capsule of 0.6 gram every.
Instructions of taking, every day 3 times, each 2, one after each meal, warm water takes, and within 14 days, is a course for the treatment of.
Embodiment 6:
Treat a preparation method for lymphadenomatous Chinese medicinal capsule, comprise the following steps:
1) decoct with water twice by the weight ratio weighting raw materials in embodiment 3, add 8 times of water gagings at every turn, first time decocts 2 hours, and second time decocts 1 hour, and merging filtrate, after filtration, is dried to fine powder;
2) by step 1) in fine powder add anhydrous grape Icing Sugar mix homogeneously;
3) above-mentioned mixed-powder is put into capsule filling machine and carry out filling, namely obtain the capsule of 0.5 gram every.
Instructions of taking, every day 3 times, each 2, one after each meal, warm water takes, and within 14 days, is a course for the treatment of.
Below the present invention be described in detail, the above, be only the preferred embodiment of the present invention, when not limiting the scope of the present invention, namely allly does impartial change according to the application's scope and modify, all should still belong in covering scope of the present invention.
Claims (3)
1. the lymphadenomatous Chinese medicinal capsule for the treatment of, it is characterized in that, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 15-20 part, Sargassum 10-15 part, Rhizoma Dioscoreae Bulbiferae 10-15 part, Radix Salviae Miltiorrhizae 20-25 part, Sanguis Draxonis 8-10 part, Rhizoma Chuanxiong 8-10 part, Rhizoma Curcumae 15-20 part, Eupolyphaga Seu Steleophaga 8-10 part, Scolopendra 8-10 part, Radix Paeoniae Rubra 10-15 part, Carapax Trionycis 15-20 part, Herba Hedyotidis Diffusae 25-30 part, Radix Fissistigmatis Glaucescentis 35-40 part, Radix Chimonanthi praecocis 35-40 part, Radix Astragali 8-10 part, Radix Pseudostellariae 10-15 part, Rhizoma Atractylodis Macrocephalae 10-15 part, Fructus Jujubae 6-8 part, Radix Angelicae Sinensis 8-10 part, Radix Rehmanniae 8-10 part, Radix Ophiopogonis 8-10 part, Fructus Lycii 8-10 part, Colla Corii Asini 15-20 part.
2. one according to claim 1 treats lymphadenomatous Chinese medicinal capsule, it is characterized in that, according to weight parts, formulated by following raw material of Chinese medicine: Spica Prunellae 18 parts, Sargassum 12 parts, Rhizoma Dioscoreae Bulbiferae 13 parts, Radix Salviae Miltiorrhizae 22 parts, Sanguis Draxonis 9 parts, Rhizoma Chuanxiong 9 parts, Rhizoma Curcumae 13 parts, Eupolyphaga Seu Steleophaga 9 parts, Scolopendra 9 parts, Radix Paeoniae Rubra 12 parts, Carapax Trionycis 18 parts, Herba Hedyotidis Diffusae 28 parts, Radix Fissistigmatis Glaucescentis 36 parts, Radix Chimonanthi praecocis 36 parts, the Radix Astragali 9 parts, Radix Pseudostellariae 12 parts, the Rhizoma Atractylodis Macrocephalae 12 parts, 7 parts, Fructus Jujubae, Radix Angelicae Sinensis 9 parts, 9 parts, the Radix Rehmanniae, Radix Ophiopogonis 9 parts, Fructus Lycii 9 parts, 18 parts, Colla Corii Asini.
3. a preparation method for the lymphadenomatous Chinese medicinal capsule for the treatment of according to claim 1, is characterized in that, comprise the following steps:
1) decoct with water twice by above-mentioned weight ratio weighting raw materials, add 8 times of water gagings at every turn, first time decocts 2 hours, and second time decocts 1 hour, and merging filtrate, after filtration, is dried to fine powder;
2) by step 1) in fine powder add anhydrous grape Icing Sugar mix homogeneously;
3) above-mentioned mixed-powder is put into capsule filling machine and carry out filling, namely obtain the capsule of every 0.5-0.6 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764228.8A CN104491716A (en) | 2014-12-11 | 2014-12-11 | Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764228.8A CN104491716A (en) | 2014-12-11 | 2014-12-11 | Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491716A true CN104491716A (en) | 2015-04-08 |
Family
ID=52933230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410764228.8A Pending CN104491716A (en) | 2014-12-11 | 2014-12-11 | Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491716A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800737A (en) * | 2015-04-27 | 2015-07-29 | 青岛大学附属医院 | Traditional Chinese medicine composition for treating lymphoma |
| CN106075223A (en) * | 2016-08-24 | 2016-11-09 | 冷国玉 | One treats lymphadenomatous Chinese medicine composition |
| CN106563106A (en) * | 2016-07-18 | 2017-04-19 | 张旭东 | A traditional Chinese medicine capsule for treating malignant lymphoma |
| CN114796418A (en) * | 2022-03-11 | 2022-07-29 | 统合生命健康科技(金华)有限公司 | Traditional Chinese medicine composition for treating lymphoma |
-
2014
- 2014-12-11 CN CN201410764228.8A patent/CN104491716A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800737A (en) * | 2015-04-27 | 2015-07-29 | 青岛大学附属医院 | Traditional Chinese medicine composition for treating lymphoma |
| CN104800737B (en) * | 2015-04-27 | 2017-12-22 | 青岛大学附属医院 | A kind of Chinese medicine composition for treating lymthoma |
| CN106563106A (en) * | 2016-07-18 | 2017-04-19 | 张旭东 | A traditional Chinese medicine capsule for treating malignant lymphoma |
| CN106075223A (en) * | 2016-08-24 | 2016-11-09 | 冷国玉 | One treats lymphadenomatous Chinese medicine composition |
| CN114796418A (en) * | 2022-03-11 | 2022-07-29 | 统合生命健康科技(金华)有限公司 | Traditional Chinese medicine composition for treating lymphoma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101537060B (en) | Medicine for treating AIDS | |
| CN104491716A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN104606580A (en) | Traditional Chinese medicine preparation with synergistic effect on chemotherapy and preparation method of traditional Chinese medicine preparation traditional Chinese medicine preparation | |
| CN105727158A (en) | Traditional Chinese medicinal capsule for treating lymphoma, and preparation method thereof | |
| CN104352603A (en) | Anti-tumor traditional Chinese medicine capable of enhancing immunity of human body | |
| CN103705733B (en) | One treats ARR Chinese medicinal capsule and preparation method thereof | |
| CN103223137B (en) | Traditional Chinese medicinal preparation for reducing blood sugar | |
| CN104707110A (en) | Traditional Chinese medicine preparation for treating pancreatic cancer and preparation method thereof | |
| CN104116908A (en) | A traditional Chinese medicine decoction for treating arrhythmia | |
| CN104127670A (en) | Traditional Chinese medicine decoction for treating arrhythmia | |
| CN104258351A (en) | Traditional Chinese medicine preparation for treating alcoholic cardiomyopathy and preparation method of preparation | |
| CN107854685A (en) | A kind of Chinese medicine composition with antitumor action and its production and use | |
| CN104399010A (en) | Traditional Chinese medicinal capsule for nursing and treating lymphoma and preparation method of traditional Chinese medicinal capsule | |
| CN105833228A (en) | Drug preparation for reversing gastric cancer drug resistance and application thereof | |
| CN105770520A (en) | Medicine preparation used for treating coronary heart disease and application thereof | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN104435580A (en) | Traditional Chinese medicine capsule for treating lymphoma and preparation method of traditional Chinese medicine capsule | |
| CN103908579A (en) | Spleen and stomach tonifying preparation for resisting side effects of chemotherapy and preparation method thereof | |
| CN104644973B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of rheumatic heart disease | |
| CN103550742A (en) | Traditional Chinese medicine for preventing postoperative metastasis of gastric cancer | |
| CN103356970A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia | |
| CN105726871A (en) | Traditional Chinese medicinal capsule for treating lymphoma and preparation method of traditional Chinese medicinal capsule | |
| CN103919995A (en) | Medicine for resisting side effects of postoperative cancer patients and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |